Neurovascular procedures are being revolutionized with the completion of the first U.S. cases using Rapid Medical’s DRIVEWIRE™ 24 deflectable access platform. Following the Food and Drug Admiinstration (FDA) validation, these groundbreaking procedures were showcased at the 21st Annual Meeting of the Society of NeuroInterventional Surgery (SNIS) in 2024. The DRIVEWIRE 24’s deformable tip ensures optimal navigation of catheters and devices in neurovascular and peripheral vascular procedures.
The DRIVEWIRE 24 redefines interventional access by providing an active deflectable tip that controls and steers a range of catheters directly to the target vessels. Unlike conventional access devices that rely on external forces, DRIVEWIRE’s active technology allows for on-demand directional adjustments, handling the complexity of navigating the vascular highway with ease. This innovative approach simplifies complex vascular navigation, making procedures faster, safer, and more efficient.
Neurovascular Advancements: Dr. Shahram Majidi Highlights DRIVEWIRE’s Potential to Improve Endovascular Procedures
Dr. Shahram Majidi of Mount Sinai Health System in New York City, who performed the first cases, stated, “DRIVEWIRE addresses a major unmet need in the endovascular space. It improves access to a range of procedures, from aneurysms to strokes and beyond. My early experience with DRIVEWIRE suggests it could make procedures faster, safer, and less expensive.”
In the initial cases, DRIVEWIRE 24 successfully guided the aspiration catheter directly to the M2 arterial occlusion, achieving excellent first-pass reperfusion. In a second case, DRIVEWIRE performed complex maneuvers to place two flow diversion devices in a large multilobed aneurysm. The device’s real-time control over the guidewire tip eliminates the need for reshaping, providing physicians with unprecedented precision and control.
Rapid Medical’s Chief Technology Officer, Giora Kornblau, highlighted the significance of this innovation: “With DRIVEWIRE, our goal was to bring new levels of access and control to our operating room while improving upon best-in-class guidewires. When physicians are looking for technologies that expand clinical possibilities and ensure patient safety, we want Rapid to be the first place they turn.”
The DRIVEWIRE 24 platform features a variable mount that articulates a wide range of microcatheters and intermediate catheters without the need for advanced guidance devices or additional mounts. This results in precise navigation via the most direct route through the neurovasculature and peripheral vasculature, enhancing the safety and effectiveness of procedures.
Neurovascular Innovation: DRIVEWIRE 24’s Active Deflectable Tip Enhances Precision and Efficiency in Vascular Interventions
Neurovascular and peripheral vascular interventions often require navigating complex and tortuous anatomy. The DRIVEWIRE 24’s active deflectable tip technology represents a significant advancement over traditional reactive guidewires. By providing on-demand directional control, DRIVEWIRE 24 allows for more precise and efficient catheter navigation, reducing procedure time and improving patient outcomes.
The introduction of DRIVEWIRE 24 into the U.S. market marks a significant milestone for Rapid Medical and the field of neurovascular intervention. The successful completion of the first U.S. cases demonstrates the platform’s potential to transform endovascular procedures, offering physicians a powerful tool to enhance their clinical capabilities.
As the medical community continues to seek advancements that improve patient care and streamline procedures, the DRIVEWIRE 24’s innovative design and performance set a new standard in the industry. Rapid Medical’s commitment to developing cutting-edge technologies is evident in the success of DRIVEWIRE 24, and the company’s ongoing efforts to bring this revolutionary platform to more healthcare providers and patients.
In conclusion, the FDA validation and subsequent successful use of DRIVEWIRE 24 in neurovascular procedures underscore the platform’s transformative potential. By providing active deflectable tip technology, DRIVEWIRE 24 enhances catheter navigation and procedural efficiency, addressing critical needs in the endovascular space. Rapid Medical’s pioneering work in this area is poised to significantly impact the future of neurovascular and peripheral vascular interventions, offering new hope and improved outcomes for patients.
Resource: Business Wire, July 23, 2024
This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.
